Scinopharm Taiwan (TPE:1789) YoY EPS Growth : -66.67% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Scinopharm Taiwan's YoY EPS Growth for the quarter that ended in Mar. 2025 was -66.67%.

Scinopharm Taiwan's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was NT$0.06.

Scinopharm Taiwan YoY EPS Growth Historical Data

The historical data trend for Scinopharm Taiwan's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan YoY EPS Growth Chart

Scinopharm Taiwan Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

33.33

-13.89

45.16

-20.00

19.44

Scinopharm Taiwan Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															260.00	28.57	-25.00	-40.00	-66.67

Scinopharm Taiwan YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Scinopharm Taiwan's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(0.43	-	0.36)	/	\| 0.36 \|
=	19.44 %

Scinopharm Taiwan's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(0.06	-	0.18)	/	\| 0.18 \|
=	-66.67 %

Scinopharm Taiwan YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines